CAMPIOTTI LEONARDO

Curriculum Vitae
Leonardo Campiotti
Born in Varese on 27/01/1967

Education and Training
Degree in Medicine and Surgery, 1994, grade 110/110 cum laude, University of Pavia

Specialist Training
Specialisation in Internal Medicine, 1999, grade 50/50
Attendance at the Leukaemia Department, MD Anderson Cancer Centre, Houston, 2000
Secondment in 2004 at the Haematology Unit (Director: Dr E. Morra), Niguarda Hospital, Milan
Placement at the Haematology Unit, Sant’Orsola Hospital, Bologna (Director: Prof. S. Tura) on multiple myeloma, 2006
Placement at the Haematology Unit, Sant’Orsola Hospital, Bologna (Director: Prof. S. Tura) on the diagnosis and treatment of indolent lymphomas, 2007

Clinical Activity
From 03/01/1994 to 07/01/1995 served as Medical Officer, Head of Health Service at the Military District of Como.
From 08/03/1995 to 30/04/1995 provided out-of-hours primary care (locum GP service) at the Local Health Authority of the Province of Varese.
From 01/01/2000 to 31/05/2000 Medical Doctor (research fellow) at the Medical Oncology Service of the Department of Internal Medicine, Varese Hospital.
From June 2000 to September 2002 Medical Consultant at the Medical Oncology Unit, Varese Hospital.
From October 2002 to March 2005 Medical Consultant at the Internal Medicine Unit and Head of the Day Hospital for Oncohaematology, Varese Hospital.
From April 2005 to 2022 University Researcher (University of Insubria) at Internal Medicine I, Varese Hospital.
From 2023 Associate Professor of Internal Medicine, University of Insubria.
Since 2012 Head of the Cellular Pathology Outpatient Clinic for the study and treatment of haematological diseases in medically complex patients with multiple comorbidities.
From June 2025, High-Level Departmental Professional Appointment at ASST Sette Laghi for inpatient and outpatient management of oncological patients with multiple comorbidities.

Teaching Activity
Since 2006, under annual rectoral appointment, Professor at the Degree Course in Medicine and Surgery, University of Insubria.
From 2005: Lecturer in Diseases of the Blood (2005–2011), Degree Course in Medicine and Surgery, University of Insubria.
Since 2012: Lecturer in Rheumatology, Degree Course in Medicine and Surgery, University of Insubria.
From 2005: Lecturer in Medical Oncology (2005–2015), Bachelor’s Degree in Laboratory Techniques, University of Insubria.
From 2016 to 2020: Lecturer in Internal Medicine, Master’s Degree in Dentistry, University of Insubria.
From 2018 to 2021: Lecturer in Medical Oncology, Nursing Degree Programme, University of Insubria (Como campus).
Since 2021: Lecturer in Internal Medicine, Bachelor’s Degree in Nursing, University of Insubria (Busto Arsizio campus).
Member of the Boards of Specialisation Schools in Medical Oncology, Internal Medicine, Geriatrics, and Emergency Medicine.
Since 2018: Member of the Executive Board of the Department of Medicine and Surgery, University of Insubria.

Research Activity
Member of the Northern Italian Leukaemia Group (NILG) and principal investigator in clinical trials for the treatment of acute leukaemias, with results published in leading international haematology journals.
Local coordinator for the GIMEMA group, participating in protocols for acute promyelocytic leukaemia, contributing to the introduction of chemotherapy-free treatment approaches.
Scientific coordinator of the agreement between the School of Specialisation in Medical Oncology and IOSI (Oncology Institute of Southern Switzerland), with publications on lymphoma cytogenetics.
Scientific coordinator of the AIL (Italian Leukaemia Association) section of Varese, supporting research on molecular biology in chronic myeloid leukaemia, minimal residual disease, and treatment discontinuation of TKI therapy in molecular remission.
Participant in the international study group on atypical chronic myeloid leukaemia (coordinator: Prof. C. Gambacorti), contributing to the identification of a novel mutation later included in the WHO classification of haematological diseases.
Promoter of studies on the influence of vitamin D on immune status in patients with colorectal cancer and chronic myeloid leukaemia. Research on the impact of BMI on response to immunotherapy in colorectal cancer patients.
Author of meta-analyses in collaboration with Prof. A. Squizzato (University of Insubria), particularly defining criteria for safe discontinuation of therapy in chronic myeloid leukaemia; work later included in European and North American guidelines.
In vitro study on the effects of apixaban on five different tumour cell lines.
Promoter of studies defining baseline metabolic tumour volume in lymphoma patients and its influence on first-line therapy response.
Research on prevention of cardiotoxicity in oncological patients and participation in programmes on early cardiac damage in diabetic and hypertensive patients.
Investigator in the REPOSI project on multimorbid elderly patients.
Ongoing studies include: appropriate use of PET in internal medicine patients; role of EBUS in mediastinal lymphadenopathy diagnosis; use of dabrafenib in rare diseases with BRAF V600-positive mutations; and the role of vitamin D in modulating immunotherapy response in lung cancer patients.